LITERATURE
INVESTOR MATERIALS

Read these publications to learn more about CF Income Trust. Investors should talk to their financial advisors about how CF Income Trust can fit into their overall investments strategy.

FORMS & LITERATURE SEC FILINGS TAX INFORMATION

Click Here for Complete List of SEC Filings

TITLE DATE FORMAT
Supplement No. 3 April 17, 2024 Open Link
8-K April 3, 2024 Open Link
10-K March 29, 2024 Open Link
Supplement No. 2 March 19, 2024 Open Link
8-K March 5, 2024 Open Link
Supplement No. 1 February 15, 2024 Open Link
Prospectus February 8, 2024 Open Link
Notice of Effectiveness February 7, 2024 Open Link
8-K February 6, 2024 Open Link
Form S-11 February 2, 2024 Open Link
Supplement No. 7 January 18, 2024 Open Link
8-K January 4, 2024 Open Link
8-K December 19, 2023 Open Link
Supplement No. 6 December 19, 2023 Open Link
8-K December 5, 2023 Open Link
Supplement No. 5 November 17, 2023 Open Link
10-Q November 14, 2023 Open Link
8-K November 2, 2023 Open Link
Supplement No. 4 October 18, 2023 Open Link
10-K October 5, 2023 Open Link
Def 14A October 5, 2023 Open Link
8-K October 4, 2023 Open Link
Schedule 14A September 22, 2023 Open Link
Supplement No. 3 September 19, 2023 Open Link
8-K September 6, 2023 Open Link
Supplement No. 2 August 15, 2023 Open Link
10-Q August 11, 2023 Open Link
Form S-11 August 9, 2023 Open Link
8-K August 8, 2023 Open Link
Supplement No. 1 July 18, 2023 Open Link
Prospectus July 17, 2023 Open Link
Notice of Effectiveness July 14, 2023 Open Link
Pre-Effective Amendment No. 1 to Post-Effective Amendment No. 3 July 13, 2023 Open Link
Form 10K/A July 13, 2023 Open Link
8-K July 6, 2023 Open Link
Post-Effective Amendments No. 3 June 30, 2023 Open Link
Supplement No. 12 June 15, 2023 Open Link
8-K June 1, 2023 Open Link
Supplement No. 11 May 16, 2023 Open Link
10-Q May 12, 2023 Open Link
8-K May 2, 2023 Open Link
Supplement No. 10 April 18, 2023 Open Link
8-K April 13, 2023 Open Link
Form 3 April 13, 2023 Open Link
Supplement No. 9 April 3, 2023 Open Link
8-K April 3, 2023 Open Link
10-K March 30, 2023 Open Link
Supplement No. 8 March 20, 2023 Open Link
8-K March 1, 2023 Open Link
Supplement No. 7 February 17, 2023 Open Link
8-K February 1, 2023 Open Link
Supplement No. 6 January 18, 2023 Open Link
8-K January 4, 2023 Open Link
Supplement No. 5 December 16, 2022 Open Link
8-K December 2, 2022 Open Link
8-K November 18, 2022 Open Link
Supplement No. 4 November 17, 2022 Open Link
10-Q November 14, 2022 Open Link
8-K November 1, 2022 Open Link
Supplement No. 3 October 17, 2022 Open Link
8-K September 30, 2022 Open Link
DEF 14A September 20, 2022 Open Link
Supplement No. 2 September 16, 2022 Open Link
8-K September 2, 2022 Open Link
Supplement No. 1 August 17, 2022 Open Link
10-Q August 11, 2022 Open Link
8-K August 1, 2022 Open Link
Prospectus July 19, 2022 Open Link
Notice of Effectiveness July 18, 2022 Open Link
Post-Effective Amendment No. 2 July 13, 2022 Open Link
8-K July 5, 2022 Open Link
Supplement No. 18 June 17, 2022 Open Link
Form 4 June 3, 2022 Open Link
8-K June 1, 2022 Open Link
Supplement No. 17 May 17, 2022 Open Link
Form 10Q May 16, 2022 Open Link
8-K May 5, 2022 Open Link
Form 4 May 4, 2022 Open Link
Supplement No. 16 May 3, 2022 Open Link
10K/A April 29, 2022 Open Link
Supplement No. 15 April 19, 2022 Open Link
8-K April 19, 2022 Open Link
8-K April 7, 2022 Open Link
10-K March 30, 2022 Open Link
Supplement No. 14 March 17, 2022 Open Link
8-K March 3, 2022 Open Link
Supplement No. 13 February 18, 2022 Open Link
8-K February 2, 2022 Open Link
Supplement No. 12 January 18, 2022 Open Link
8-K January 4, 2022 Open Link
Supplement No. 11 December 16, 2021 Open Link
Supplement No. 10 December 2, 2021 Open Link
8-K November 23, 2021 Open Link
Supplement No. 9 November 16, 2021 Open Link
10-Q November 15, 2021 Open Link
8-K November 1, 2021 Open Link
Supplement No. 8 October 22, 2021 Open Link
10-Q/A October 22, 2021 Open Link
Supplement No. 7 October 18, 2021 Open Link
8-K October 5, 2021 Open Link
Supplement No. 6 September 16, 2021 Open Link
8-K September 1, 2021 Open Link
Supplement No. 5 August 17, 2021 Open Link
8-K August 16, 2021 Open Link
10-Q August 13, 2021 Open Link
Supplement No. 4 July 30, 2021 Open Link
8-K July 29, 2021 Open Link
Supplement No. 3 July 20, 2021 Open Link
8-K July 9, 2021 Open Link
8-K July 1, 2021 Open Link
Supplement No. 2 June 15, 2021 Open Link
Supplement No. 1 June 8, 2021 Open Link
Prospectus June 3, 2021 Open Link
Notice of Effectiveness June 3, 2021 Open Link
8-K June 2, 2021 Open Link
Post-Effective Amendment No. 1 May 25, 2021 Open Link
Supplement No. 13 May 18, 2021 Open Link
10-Q May 17, 2021 Open Link
8-K April 30, 2021 Open Link
DEF 14A April 19, 2021 Open Link
Supplement No. 12 April 16, 2021 Open Link
Supplement No. 11 April 5, 2021 Open Link
8-K March 31, 2021 Open Link
Supplement No. 10 March 30, 2021 Open Link
10-K March 25, 2021 Open Link
Supplement No. 9 March 15, 2021 Open Link
Supplement No. 8 March 5, 2021 Open Link
8-K/A March 4, 2021 Open Link
8-K March 3, 2021 Open Link
Supplement No. 7 February 22, 2021 Open Link
Form 3 February 22, 2021 Open Link
8-K February 22, 2021 Open Link
Supplement No. 6 January 19, 2021 Open Link
Supplement No. 5 December 17, 2020 Open Link
8-K November 30, 2020 Open Link
Supplement No. 4 November 17, 2020 Open Link
10-Q November 13, 2020 Open Link
8-K October 30, 2020 Open Link
Supplement No. 3 October 15, 2020 Open Link
Supplement No. 2 September 15, 2020 Open Link
8-K August 31, 2020 Open Link
Supplement No. 1 August 17, 2020 Open Link
8-K August 14, 2020 Open Link
10-Q August 13, 2020 Open Link
Prospectus August 12, 2020

CONTACT US FOR FURTHER INFORMATION

CF Income Trust’s diversified investment strategy enables the company to selectively pursue diverse investment opportunities across various commercial real estate property types and investment cycles.

Strategy &
Offering Highlights

LEARN MORE

Portfolio &
Performance

VIEW OUR METRICS

Forms &
Literature

VISIT OUR LIBRARY

You are leaving this site and will be redirected to third party website.

You are leaving this site and will be redirected to third party website.

You are leaving this site and will be redirected to third party website.